[Breast cancer adjuvant endocrine treatment].
Endocrine treatment of early stage breast cancer may be summarized in two settings. (1) Early breast cancer, premenopausal women: tamoxifen; ovarian suppression is an acceptable option. (2) Early breast cancer, menopausal women: aromatase inhibitors, for at least 2 to 3 years; extended treatment beyond 5 years of tamoxifen may be discussed.